Immune checkpoint inhibitors in patients with pre-existing psoriasis: safety and efficacy
Guardado en:
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
BMJ Publishing Group
2021
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/2404ddf91eb64426ad24a0c1ae12dd85 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:2404ddf91eb64426ad24a0c1ae12dd85 |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:2404ddf91eb64426ad24a0c1ae12dd852021-11-26T00:00:07ZImmune checkpoint inhibitors in patients with pre-existing psoriasis: safety and efficacy10.1136/jitc-2021-0030662051-1426https://doaj.org/article/2404ddf91eb64426ad24a0c1ae12dd852021-10-01T00:00:00Zhttps://jitc.bmj.com/content/9/10/e003066.fullhttps://doaj.org/toc/2051-1426Andrew HaydonJessica C HasselJeffrey A SosmanSunandana ChandraRyan SullivanMario E LacoutureMeghan J MooradianAlexander MenziesDouglas B JohnsonFei YePrachi BhaveSteven T ChenGeorgina LongBriana Rose HalleFarzana Y ZamanAnna K DewanRebecca IrlmeierParas MehtaNicholas R KurtanskyJacob S ChoiTracey S OttoFlorentia DimitriouVeronica M RotembergBMJ Publishing GrouparticleNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENJournal for ImmunoTherapy of Cancer, Vol 9, Iss 10 (2021) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 |
| spellingShingle |
Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 Andrew Haydon Jessica C Hassel Jeffrey A Sosman Sunandana Chandra Ryan Sullivan Mario E Lacouture Meghan J Mooradian Alexander Menzies Douglas B Johnson Fei Ye Prachi Bhave Steven T Chen Georgina Long Briana Rose Halle Farzana Y Zaman Anna K Dewan Rebecca Irlmeier Paras Mehta Nicholas R Kurtansky Jacob S Choi Tracey S Otto Florentia Dimitriou Veronica M Rotemberg Immune checkpoint inhibitors in patients with pre-existing psoriasis: safety and efficacy |
| format |
article |
| author |
Andrew Haydon Jessica C Hassel Jeffrey A Sosman Sunandana Chandra Ryan Sullivan Mario E Lacouture Meghan J Mooradian Alexander Menzies Douglas B Johnson Fei Ye Prachi Bhave Steven T Chen Georgina Long Briana Rose Halle Farzana Y Zaman Anna K Dewan Rebecca Irlmeier Paras Mehta Nicholas R Kurtansky Jacob S Choi Tracey S Otto Florentia Dimitriou Veronica M Rotemberg |
| author_facet |
Andrew Haydon Jessica C Hassel Jeffrey A Sosman Sunandana Chandra Ryan Sullivan Mario E Lacouture Meghan J Mooradian Alexander Menzies Douglas B Johnson Fei Ye Prachi Bhave Steven T Chen Georgina Long Briana Rose Halle Farzana Y Zaman Anna K Dewan Rebecca Irlmeier Paras Mehta Nicholas R Kurtansky Jacob S Choi Tracey S Otto Florentia Dimitriou Veronica M Rotemberg |
| author_sort |
Andrew Haydon |
| title |
Immune checkpoint inhibitors in patients with pre-existing psoriasis: safety and efficacy |
| title_short |
Immune checkpoint inhibitors in patients with pre-existing psoriasis: safety and efficacy |
| title_full |
Immune checkpoint inhibitors in patients with pre-existing psoriasis: safety and efficacy |
| title_fullStr |
Immune checkpoint inhibitors in patients with pre-existing psoriasis: safety and efficacy |
| title_full_unstemmed |
Immune checkpoint inhibitors in patients with pre-existing psoriasis: safety and efficacy |
| title_sort |
immune checkpoint inhibitors in patients with pre-existing psoriasis: safety and efficacy |
| publisher |
BMJ Publishing Group |
| publishDate |
2021 |
| url |
https://doaj.org/article/2404ddf91eb64426ad24a0c1ae12dd85 |
| work_keys_str_mv |
AT andrewhaydon immunecheckpointinhibitorsinpatientswithpreexistingpsoriasissafetyandefficacy AT jessicachassel immunecheckpointinhibitorsinpatientswithpreexistingpsoriasissafetyandefficacy AT jeffreyasosman immunecheckpointinhibitorsinpatientswithpreexistingpsoriasissafetyandefficacy AT sunandanachandra immunecheckpointinhibitorsinpatientswithpreexistingpsoriasissafetyandefficacy AT ryansullivan immunecheckpointinhibitorsinpatientswithpreexistingpsoriasissafetyandefficacy AT marioelacouture immunecheckpointinhibitorsinpatientswithpreexistingpsoriasissafetyandefficacy AT meghanjmooradian immunecheckpointinhibitorsinpatientswithpreexistingpsoriasissafetyandefficacy AT alexandermenzies immunecheckpointinhibitorsinpatientswithpreexistingpsoriasissafetyandefficacy AT douglasbjohnson immunecheckpointinhibitorsinpatientswithpreexistingpsoriasissafetyandefficacy AT feiye immunecheckpointinhibitorsinpatientswithpreexistingpsoriasissafetyandefficacy AT prachibhave immunecheckpointinhibitorsinpatientswithpreexistingpsoriasissafetyandefficacy AT steventchen immunecheckpointinhibitorsinpatientswithpreexistingpsoriasissafetyandefficacy AT georginalong immunecheckpointinhibitorsinpatientswithpreexistingpsoriasissafetyandefficacy AT brianarosehalle immunecheckpointinhibitorsinpatientswithpreexistingpsoriasissafetyandefficacy AT farzanayzaman immunecheckpointinhibitorsinpatientswithpreexistingpsoriasissafetyandefficacy AT annakdewan immunecheckpointinhibitorsinpatientswithpreexistingpsoriasissafetyandefficacy AT rebeccairlmeier immunecheckpointinhibitorsinpatientswithpreexistingpsoriasissafetyandefficacy AT parasmehta immunecheckpointinhibitorsinpatientswithpreexistingpsoriasissafetyandefficacy AT nicholasrkurtansky immunecheckpointinhibitorsinpatientswithpreexistingpsoriasissafetyandefficacy AT jacobschoi immunecheckpointinhibitorsinpatientswithpreexistingpsoriasissafetyandefficacy AT traceysotto immunecheckpointinhibitorsinpatientswithpreexistingpsoriasissafetyandefficacy AT florentiadimitriou immunecheckpointinhibitorsinpatientswithpreexistingpsoriasissafetyandefficacy AT veronicamrotemberg immunecheckpointinhibitorsinpatientswithpreexistingpsoriasissafetyandefficacy |
| _version_ |
1718409954182823936 |